BRD3
BRD3 (bromodomain containing 3; also RING3L, ORFX, KIAA0043 and FSHRG2) is a nuclear chromatin reader of the BET family. It binds acetylated histones and acetylated non-histone proteins to control gene expression and chromatin structure. Browse Assay Genie's current range of BRD3 research reagents below, or read on for the biology behind the target.
BRD3 is a chromatin reader that recognises and binds acetylated histones, thereby controlling gene expression and remodelling chromatin structures. It recruits transcription factors and coactivators to target gene sites and activates the RNA polymerase II machinery for transcriptional elongation. In vitro, it binds acetylated lysine residues on the N-terminus of histones H2A, H2B, H3 and H4.
BRD3 also acts on non-histone acetylated proteins. It binds the transcription factors GATA1 and GATA2, and regulates transcription by promoting the binding of GATA1 to its targets. In endoderm differentiation, BRD3 associates with the long non-coding RNA DIGIT. Binding to DIGIT drives BRD3 into liquid-liquid phase separation, which promotes its binding to histone H3 acetylated at Lys-18 (H3K18ac) and induces endoderm gene expression.
The BRD3 gene was identified through its homology to the gene encoding RING3, a serine/threonine kinase, which explains the alias RING3L. It lies at 9q34, a region that contains several major histocompatibility complex genes. HGNC places it in the bromodomain and extra-terminal domain (BET) family, alongside BRD2 and BRD4. The BRD3 protein is the product of this gene, and the mouse ortholog is Brd3.
BRD3 reads acetylated histone H2A, H2B, H3 and H4 tails, making it a model for studying how acetylation marks control chromatin structure.
BRD3 recruits transcription factors and coactivators and activates RNA polymerase II machinery, linking histone acetylation to transcriptional elongation.
BRD3 phase separation with lncRNA DIGIT and binding to H3K18ac induce endoderm gene expression, a route for studying lineage specification.
BRD3 binds acetylated GATA1 and GATA2 and promotes GATA1 binding to its targets, connecting chromatin readers to transcription factor control.
BRD3 is a chromatin reader that binds acetylated histones and controls gene expression. It recruits transcription factors and coactivators to target genes and activates RNA polymerase II machinery for transcriptional elongation. It also binds acetylated GATA1 and GATA2, and promotes GATA1 binding to its targets.
BRD3 stands for bromodomain containing 3; UniProt names it bromodomain-containing protein 3. Aliases and previous symbols include RING3L, ORFX, KIAA0043 and FSHRG2. RING3L reflects the gene's homology to RING3. HGNC lists it in the BET family and the wider bromodomain-containing group.
BRD3 belongs to the BET (bromodomain and extra-terminal domain) family, which also includes BRD2 and BRD4. A mouse ortholog, Brd3, is recorded. Check the datasheet of any product for its validated reactivity.
Other BET family and bromodomain-containing proteins involved in chromatin reading and transcriptional regulation.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q15059; product specifications from Assay Genie datasheets.